News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT)'s Muscle Drug Shows Positive Signs, Shares Jump


8/31/2012 7:10:25 AM

Shares of Sarepta Therapeutics Inc rose as much as 20 percent to a 19-month high on Thursday after a Missouri TV station said the company's experimental drug for muscle weakness and loss of muscle tissue showed positive signs in one of the 12 enrolled patients. The drug Eteplirsen is being tested in a mid-stage trial to treat patients with Duchenne Muscular Dystrophy (DMD), a genetic disorder that causes severe and progressive muscle loss in boys and has no approved treatments.

Read at RTT News
Read at Market Watch
Read at Reuters


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES